MA42973A - Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis - Google Patents

Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis

Info

Publication number
MA42973A
MA42973A MA042973A MA42973A MA42973A MA 42973 A MA42973 A MA 42973A MA 042973 A MA042973 A MA 042973A MA 42973 A MA42973 A MA 42973A MA 42973 A MA42973 A MA 42973A
Authority
MA
Morocco
Prior art keywords
hyperimmunity
personalized
psoriasis
manufacture
treatment
Prior art date
Application number
MA042973A
Other languages
English (en)
Inventor
Chiurciu Constantin
Victor Patrascu Ionel
Iuliana Mihai
Lucica Sima
Chiurciu Viorica
Original Assignee
Romvac Company Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Romvac Company Sa filed Critical Romvac Company Sa
Publication of MA42973A publication Critical patent/MA42973A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
MA042973A 2015-10-16 2016-01-08 Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis MA42973A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201500735A RO130965A8 (ro) 2015-10-16 2015-10-16 Producerea şi utilizarea oului hiperimun personalizat () în tratamentul psoriazisului

Publications (1)

Publication Number Publication Date
MA42973A true MA42973A (fr) 2018-08-22

Family

ID=55754390

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042973A MA42973A (fr) 2015-10-16 2016-01-08 Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis

Country Status (4)

Country Link
EP (1) EP3362092A1 (fr)
MA (1) MA42973A (fr)
RO (1) RO130965A8 (fr)
WO (1) WO2017065626A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO132299A3 (ro) * 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()
US11319382B1 (en) 2021-06-28 2022-05-03 King Abdulaziz University Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1068524C (zh) * 1997-06-23 2001-07-18 叶庆炜 一种治疗顽症牛皮癣的药物
WO1999036077A1 (fr) * 1998-01-19 1999-07-22 Dcv, Inc. Composition et methode de traitement et de prevention de l'arthrite et/ou de maladies auto-immunes
AU1818600A (en) * 1998-11-16 2000-06-05 Genway Biotech, Inc. Generation of antibodies using polynucleotide vaccination in avian species
AU2007291891B2 (en) * 2006-08-31 2013-10-31 A.C.N. 135 493 391 Pty Ltd Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions
US20100233162A1 (en) * 2007-08-30 2010-09-16 Bengt Agerup LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
JP5439127B2 (ja) * 2009-11-13 2014-03-12 株式会社さいわいメディカル 乾癬又はアトピー性皮膚炎治療剤
RO129645B1 (ro) * 2014-02-25 2022-05-30 Romvac Company S.A. PROCEDEU DE OBŢINERE A IMUNOGLO- BULINELOR IgY
RO130213A8 (ro) * 2014-10-29 2017-06-30 Romvac Company S.A. Producerea şi folosirea oului hiperimun - pc2

Also Published As

Publication number Publication date
RO130965A8 (ro) 2017-06-30
WO2017065626A1 (fr) 2017-04-20
RO130965A0 (ro) 2016-03-30
EP3362092A1 (fr) 2018-08-22

Similar Documents

Publication Publication Date Title
MA45192A (fr) Traitement d'association
DK3641819T3 (da) Anvendelse af cannabidiol i behandling af tuberøst sklerosekompleks
MA42819A (fr) Procédés pour le traitement d'infections virales à arenaviridae et coronaviridae
MA39960A (fr) Composés imidazo[4,5c]quinoline-2-one et leur utilisation dans le traitement du cancer
DK3313401T3 (da) Nanopartikler omfattende sirolimus og albumin til anvendelse i behandling af epithelioide celletumorer
MA45481A (fr) Utilisation d'exosomes pour le traitement de maladies
MA46566A (fr) Oxystérols et leurs procédés d'utilisation
DK3233130T3 (da) Nukleinsyrekonstruktioner og genterapivektorer til anvendelse i behandlingen af wilson-sygdom
MA40008A (fr) Antagoniste actrii pour le traitement et la prevention d'un ulcere cutane chez un sujet ayant l'anemie
MA45073A (fr) Nouveaux peptides, combinaison de peptides et d'échafaudages destinés à être utilisés dans le traitement immunothérapeutique de divers cancers
DK3432899T3 (da) Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis
DK3325509T3 (da) Anti-tfr antistoffer og deres anvendelse i behandling af proliferative og inflammatoriske lidelser
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
DK3442513T3 (da) Anvendelse af cannabidiolsyre i behandling af autismespektrumforstyrrelse og forbundne forstyrrelser
MA47450A (fr) Sulfinylpyridines et leur utilisation dans le traitement du cancer
DK2945642T3 (da) Faktor 1 protein til anvendelse i behandling eller forebyggelse af sygdomme
DK3391902T3 (da) Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati
MA43361A (fr) Composition pour le soin et la protection de cultures
MA44762A (fr) Sémaglutide utilisé dans le traitement de maladies cardiovasculaires
FR3022917B1 (fr) Materiau d'electrode et son utilisation pour la fabrication d'anode inerte
MA42915A (fr) Pyridines et leur utilisation dans le traitement du cancer
DK3149049T3 (da) Il-22 til anvendelse til behandling af stofskiftesygdomme
DK3386916T3 (da) Forbedringer i produktionen af silicium-nanopartikler og anvendelser deraf
MA42973A (fr) Fabrication et utilisation d' uf hyper-immun personnalisé dans le traitement du psoriasis
MA39912A (fr) Dérivés de 2-aryl-4-hydroxy-1,3-thiazole comme antagonistes du trpm8, et leur utilisation dans le traitement de la neuralgie, de la douleur, de la bpco et de l'asthme.